SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) /
The debt of SCINAI IMMUNOTHERAPEUTICS LTD. over the past 5 years
Chart SCINAI IMMUNOTHERAPEUTICS LTD.: liquid cash, total debt, net cash, fiscal 2021–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, SCINAI IMMUNOTHERAPEUTICS LTD. had liquid cash of $1.66M and total debt of $294K: net cash of $1.37M. It had more liquid cash than debt at 2 of the 5 year-ends shown. Total debt was highest at the end of fiscal 2021 ($27.54M) and lowest at the end of fiscal 2024 ($260K).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $1.66M | $294K | $1.37M |
| 2024ended Dec 31, 2024 | $1.96M | $260K | $1.7M |
| 2023ended Dec 31, 2023 | $4.87M | $19.37M | -$14.5M |
| 2022ended Dec 31, 2022 | $14.07M | $20.08M | -$6.01M |
| 2021ended Dec 31, 2021 | $17.37M | $27.54M | -$10.16M |
Fiscal years as SCINAI IMMUNOTHERAPEUTICS LTD. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on SCINAI IMMUNOTHERAPEUTICS LTD.
- The profitability of SCINAI IMMUNOTHERAPEUTICS LTD.
- The cash flow of SCINAI IMMUNOTHERAPEUTICS LTD.
- All of SCINAI IMMUNOTHERAPEUTICS LTD.'s financials, charted
Companies of a similar size
- PIIMPINJ, INC.
- NXSTNEXSTAR MEDIA GROUP, INC.
- HASIHA SUSTAINABLE INFRASTRUCTURE CAPITAL, INC.
- PSMTPriceSmart, Inc.
- AXAxos Financial, Inc.
Not investment advice. This page shows what SCINAI IMMUNOTHERAPEUTICS LTD. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.